- ISIN
- US1914592050
- Sector
- Healthcare
- Industry
- Medical Devices
Highlights
- Market Cap
- $4.45B
- Enterprise Value
- $4.74B
- EPS (TTM)
- $5.44
- PE Ratio
- 6.25
- PEG Ratio
- 1.18
- Total Revenue (TTM)
- $4.65B
- Gross Profit (TTM)
- $3.44B
- EBITDA (TTM)
- $1.13B
- Year Range
- $31.82 - $105.60
- Target Price
- $318.50
- ROA (TTM)
- 25.54%
- ROE (TTM)
- 36.82%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
CHEOY Performance Chart
CochLear Ltd ADR (CHEOY) is down 60.2% since the beginning of the year. At $34 per share, CHEOY is trading 67.8% below its 52-week high of $106. Investors who bought $1,000 worth of CHEOY shares 5 years ago would now be looking at an investment worth $421.
Loading charts...
Returns By Period
CochLear Ltd ADR (CHEOY) has returned -60.19% so far this year and -60.17% over the past 12 months. Over the last ten years, CHEOY has returned -1.15% per year, falling short of the S&P 500 Index benchmark, which averaged 13.66% annually.
CochLear Ltd ADR
- 1D
- -3.10%
- 1M
- -5.01%
- YTD
- -60.19%
- 6M
- -62.17%
- 1Y
- -60.17%
- 3Y*
- -24.17%
- 5Y*
- -15.87%
- 10Y*
- -1.15%
Benchmark (S&P 500 Index)
- 1D
- -0.74%
- 1M
- 4.90%
- YTD
- 10.35%
- 6M
- 10.28%
- 1Y
- 26.52%
- 3Y*
- 20.83%
- 5Y*
- 12.30%
- 10Y*
- 13.66%
CHEOY Monthly Returns History
Based on dividend-adjusted daily data since Sep 16, 2009, CHEOY's average daily return is +0.03%, while the average monthly return is +0.68%. At this rate, an investment would double in approximately 8.5 years.
Historically, 58% of months were positive and 42% were negative. The best month was Oct 2011 with a return of +39.3%, while the worst month was Sep 2011 at -45.9%. The longest winning streak lasted 8 consecutive months, and the longest losing streak was 7 months.
On a daily basis, CHEOY closed higher 41% of trading days. The best single day was Mar 13, 2020 with a return of +29.2%, while the worst single day was Apr 22, 2026 at -39.0%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 8.21% | -24.52% | -15.35% | -42.42% | 6.05% | -5.72% | -60.19% | ||||||
| 2025 | 11.25% | -18.91% | 3.73% | 4.46% | 0.14% | 13.39% | 4.09% | -4.10% | -5.51% | 1.36% | -1.36% | -6.43% | -2.07% |
| 2024 | -2.11% | 14.46% | -2.44% | -5.02% | 2.77% | 2.40% | 3.08% | -11.04% | -3.01% | -3.50% | 6.26% | -10.13% | -10.45% |
| 2023 | 8.97% | -0.05% | 6.15% | 2.99% | -2.94% | -3.37% | 5.33% | 9.10% | -6.12% | -6.56% | 17.39% | 12.77% | 49.01% |
| 2022 | -13.23% | 19.61% | 4.30% | -4.28% | -2.35% | -13.97% | 9.71% | -2.26% | -13.80% | 1.36% | 14.90% | -5.34% | -11.29% |
| 2021 | 3.32% | 13.45% | -6.63% | 7.64% | 0.40% | 8.61% | -4.16% | -5.75% | -6.74% | 5.59% | -7.62% | 2.48% | 8.18% |
Benchmark Metrics
CochLear Ltd ADR has an annualized alpha of -0.70%, beta of 0.72, and R2 of 0.13 versus S&P 500 Index. Calculated based on daily prices since September 17, 2009.
- This stock participated in 110.47% of S&P 500 Index downside but only 69.56% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.13 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- -0.70%
- Beta
- 0.72
- R²
- 0.13
- Upside Capture
- 69.56%
- Downside Capture
- 110.47%
Return for Risk
Risk / Return Rank
CHEOY ranks 3 for risk / return — in the bottom 3% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for CochLear Ltd ADR (CHEOY) and compare them to S&P 500 Index.
| CHEOY | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -3.41 | ||
| Sortino ratioReturn per unit of downside risk | -4.65 | ||
| Omega ratioGain probability vs. loss probability | 0.67 | 1.41 | -0.73 |
| Calmar ratioReturn relative to maximum drawdown | -0.88 | 2.93 | -3.81 |
| Martin ratioReturn relative to average drawdown | -2.06 | 13.52 | -15.58 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Dividends
Dividend History
CochLear Ltd ADR provided a 4.29% dividend yield over the last twelve months, with an annual payout of $1.46 per share. The company has been increasing its dividends for 5 consecutive years.
| Period | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $1.46 | $1.38 | $1.37 | $1.10 | $1.06 | $0.97 | $0.48 | $1.05 | $1.03 | $1.47 | $1.68 | $0.38 |
Dividend yield | 4.29% | 1.60% | 1.53% | 1.08% | 1.54% | 1.23% | 0.66% | 1.33% | 1.66% | 2.19% | 3.79% | 1.10% |
Monthly Dividends
The table displays the monthly dividend distributions for CochLear Ltd ADR. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | $0.00 | $0.00 | $0.76 | $0.00 | $0.00 | $0.00 | $0.76 | ||||||
| 2025 | $0.00 | $0.00 | $0.69 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.70 | $0.00 | $0.00 | $0.00 | $1.38 |
| 2024 | $0.00 | $0.00 | $0.66 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.71 | $0.00 | $0.00 | $0.00 | $1.37 |
| 2023 | $0.00 | $0.00 | $0.53 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.57 | $0.00 | $0.00 | $0.00 | $1.10 |
| 2022 | $0.00 | $0.00 | $0.56 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.50 | $0.00 | $0.00 | $0.00 | $1.06 |
| 2021 | $0.00 | $0.00 | $0.45 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.52 | $0.00 | $0.00 | $0.00 | $0.97 |
Dividend Yield & Payout
Dividend Yield
CochLear Ltd ADR has a dividend yield of 4.29%, which is quite average when compared to the overall market.
Payout Ratio
CochLear Ltd ADR has a payout ratio of 76.77%, which is quite average when compared to the overall market. This suggests that CochLear Ltd ADR strikes a balance between reinvesting profits for growth and paying dividends to shareholders.
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the CochLear Ltd ADR. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the CochLear Ltd ADR was 71.45%, occurring on Apr 29, 2026. The portfolio has not yet recovered.
The current CochLear Ltd ADR drawdown is 69.59%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2026 bear market2026 | -71.45%Apr 2026 | 1y 9mo | — | 1y 10moJul 2024 - now |
2011 bear market2011 | -50.62%Oct 2011 | 5mo 10d | 4y 6mo | 4y 11moApr 2011 - Apr 2016 |
COVID crash2020 | -47.40%Mar 2020 | 1mo 2d | 7mo 21d | 8mo 23dFeb 2020 - Nov 2020 |
Bear market2022 | -36.28%Oct 2022 | 1y 2mo | 1y 1mo | 2y 4moJul 2021 - Dec 2023 |
Rate-hike selloffLate 2018 | -28.49%Nov 2018 | 2mo 20d | 1y 16d | 1y 3moAug 2018 - Dec 2019 |
Drawdown Indicators
| CHEOY | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -71.45% | -56.78% | -14.67% |
Max Drawdown (1Y)Largest decline over 1 year | -68.73% | -9.10% | -59.63% |
Max Drawdown (3Y)Largest decline over 3 years | -71.45% | -18.90% | -52.55% |
Max Drawdown (5Y)Largest decline over 5 years | -71.45% | -25.43% | -46.02% |
Max Drawdown (10Y)Largest decline over 10 years | -71.45% | -33.92% | -37.53% |
Current DrawdownCurrent decline from peak | -69.59% | -0.74% | -68.85% |
Average DrawdownAverage peak-to-trough decline | -15.28% | -10.72% | -4.56% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 29.19% | 1.97% | +27.22% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of CochLear Ltd ADR over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how CochLear Ltd ADR is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for CHEOY, comparing it with other companies in the Medical Devices industry. Currently, CHEOY has a P/E ratio of 6.2. This P/E ratio is considered low compared to industry peers, which may suggest that the stock is undervalued or that the company has weaker growth prospects.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for CHEOY compared to other companies in the Medical Devices industry. CHEOY currently has a PEG ratio of 1.2. This PEG ratio is close to the industry average, suggesting the stock’s valuation is balanced against its growth outlook.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for CHEOY relative to other companies in the Medical Devices industry. Currently, CHEOY has a P/S ratio of 1.0. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for CHEOY in comparison with other companies in the Medical Devices industry. Currently, CHEOY has a P/B value of 2.3. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with CHEOY
Add CochLear Ltd ADR to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with CHEOY